Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Immune Support Formula Licensed From UC Berkeley Launched
Berkeley BioSciences, Inc. announces the launch of ActivaMune -- an advanced immune support formula exclusively licensed from UC Berkeley.
- Collagen Nutraceuticals Files for Patent Protection on New Invention “Reversitall (TM)”
Collagen Nutraceuticals, Inc. announces the filing of patent protection for the manufacturing method and the use of its latest innovation – 'Reversitall (TM' – an extract from a blend of red wine, Muscadine grapes, grape cluster stems, and grape vine.
- Collagen Nutraceuticals Files for Patent Protection on New Invention “Reversitall (TM)”
Collagen Nutraceuticals, Inc. announces the filing of patent protection for the manufacturing method and the use of its latest innovation – 'Reversitall (TM' – an extract from a blend of red wine, Muscadine grapes, grape cluster stems, and grape vine.
- Collagen Nutraceuticals Files for Patent Protection on New Invention “Reversitall (TM)”
Collagen Nutraceuticals, Inc. announces the filing of patent protection for the manufacturing method and the use of its latest innovation – 'Reversitall (TM' – an extract from a blend of red wine, Muscadine grapes, grape cluster stems, and grape vine.
- Collagen Nutraceuticals Files for Patent Protection on New Invention “Reversitall (TM)”
Collagen Nutraceuticals, Inc. announces the filing of patent protection for the manufacturing method and the use of its latest innovation – 'Reversitall (TM' – an extract from a blend of red wine, Muscadine grapes, grape cluster stems, and grape vine.
- Collagen Nutraceuticals Files for Patent Protection on New Invention “Reversitall (TM)”
Collagen Nutraceuticals, Inc. announces the filing of patent protection for the manufacturing method and the use of its latest innovation – 'Reversitall (TM' – an extract from a blend of red wine, Muscadine grapes, grape cluster stems, and grape vine.
- Collagen Nutraceuticals Files for Patent Protection on New Invention “Reversitall (TM)”
Collagen Nutraceuticals, Inc. announces the filing of patent protection for the manufacturing method and the use of its latest innovation – 'Reversitall (TM' – an extract from a blend of red wine, Muscadine grapes, grape cluster stems, and grape vine.
- Metagenics, Inc. Awarded Three Patents for the Discovery of Luduxin(TM) and Tetrase(TM), All-Natural Agents Derived from Hops
Metagenics, Inc. has announced that it has been awarded three new patents for discoveries relating to Luduxin(TM) and Tetrase(TM), two all-natural selective kinase response modifier (SKRM) formulations.
- Metagenics, Inc. Awarded Three Patents for the Discovery of Luduxin(TM) and Tetrase(TM), All-Natural Agents Derived from Hops
Metagenics, Inc. has announced that it has been awarded three new patents for discoveries relating to Luduxin(TM) and Tetrase(TM), two all-natural selective kinase response modifier (SKRM) formulations.
- Metagenics, Inc. Awarded Three Patents for the Discovery of Luduxin(TM) and Tetrase(TM), All-Natural Agents Derived from Hops
Metagenics, Inc. has announced that it has been awarded three new patents for discoveries relating to Luduxin(TM) and Tetrase(TM), two all-natural selective kinase response modifier (SKRM) formulations.
- Lipogen PS Awarded Patent for Infant Formula
Lipogen, Israel, has developed an advanced delivery system for its Lipogen PS phosphatidylserine functional ingredient for safe and effective use in infant formula and baby foods and has been awarded a patent for this unique formulation, which will be introduced at SupplySide West in Las Vegas next week.
- Lipogen PS Awarded Patent for Infant Formula
Lipogen, Israel, has developed an advanced delivery system for its Lipogen PS phosphatidylserine functional ingredient for safe and effective use in infant formula and baby foods and has been awarded a patent for this unique formulation, which will be introduced at SupplySide West in Las Vegas next week.
- Lipogen PS Awarded Patent for Infant Formula
Lipogen, Israel, has developed an advanced delivery system for its Lipogen PS phosphatidylserine functional ingredient for safe and effective use in infant formula and baby foods and has been awarded a patent for this unique formulation, which will be introduced at SupplySide West in Las Vegas next week.
- Patented Drying Technology Assures Low Temperature Heat Transfer At the Speed of Light
MCD Technologies, Inc. announces global availability of dryers and evaporators that utilize their patented Refractance Window® technology. The custom-designed equipment enables products to be dried at low temperatures (140° to 160°F / 60° to 71°C or less), assuring superior retention of nutrients, colors, flavors and aromas of even delicate, heat sensitive products.
- Patented Drying Technology Assures Low Temperature Heat Transfer At the Speed of Light
MCD Technologies, Inc. announces global availability of dryers and evaporators that utilize their patented Refractance Window® technology. The custom-designed equipment enables products to be dried at low temperatures (140° to 160°F / 60° to 71°C or less), assuring superior retention of nutrients, colors, flavors and aromas of even delicate, heat sensitive products.
- Patented Drying Technology Assures Low Temperature Heat Transfer At the Speed of Light
MCD Technologies, Inc. announces global availability of dryers and evaporators that utilize their patented Refractance Window® technology. The custom-designed equipment enables products to be dried at low temperatures (140° to 160°F / 60° to 71°C or less), assuring superior retention of nutrients, colors, flavors and aromas of even delicate, heat sensitive products.
- Patented Drying Technology Assures Low Temperature Heat Transfer At the Speed of Light
MCD Technologies, Inc. announces global availability of dryers and evaporators that utilize their patented Refractance Window® technology. The custom-designed equipment enables products to be dried at low temperatures (140° to 160°F / 60° to 71°C or less), assuring superior retention of nutrients, colors, flavors and aromas of even delicate, heat sensitive products.
- Tate & Lyle Ventures and Scottish Enterprise’s Scottish Venture Fund acquire BioFilm Limited
Tate & Lyle Ventures and Scottish Enterprise’s Scottish Venture Fund have acquired BioFilm Limited, a subsidiary of Devro plc and integrated manufacturer of dissolvable / edible films that carry active ingredients, designed for use in the nutraceutical and medical markets, through a newly formed company, BioFilm Holdings Limited.
- Tate & Lyle Ventures and Scottish Enterprise’s Scottish Venture Fund acquire BioFilm Limited
Tate & Lyle Ventures and Scottish Enterprise’s Scottish Venture Fund have acquired BioFilm Limited, a subsidiary of Devro plc and integrated manufacturer of dissolvable / edible films that carry active ingredients, designed for use in the nutraceutical and medical markets, through a newly formed company, BioFilm Holdings Limited.
- Tate & Lyle Ventures and Scottish Enterprise’s Scottish Venture Fund acquire BioFilm Limited
Tate & Lyle Ventures and Scottish Enterprise’s Scottish Venture Fund have acquired BioFilm Limited, a subsidiary of Devro plc and integrated manufacturer of dissolvable / edible films that carry active ingredients, designed for use in the nutraceutical and medical markets, through a newly formed company, BioFilm Holdings Limited.
- Tate & Lyle Ventures and Scottish Enterprise’s Scottish Venture Fund acquire BioFilm Limited
Tate & Lyle Ventures and Scottish Enterprise’s Scottish Venture Fund have acquired BioFilm Limited, a subsidiary of Devro plc and integrated manufacturer of dissolvable / edible films that carry active ingredients, designed for use in the nutraceutical and medical markets, through a newly formed company, BioFilm Holdings Limited.
- Tate & Lyle Ventures and Scottish Enterprise’s Scottish Venture Fund acquire BioFilm Limited
Tate & Lyle Ventures and Scottish Enterprise’s Scottish Venture Fund have acquired BioFilm Limited, a subsidiary of Devro plc and integrated manufacturer of dissolvable / edible films that carry active ingredients, designed for use in the nutraceutical and medical markets, through a newly formed company, BioFilm Holdings Limited.
- Tate & Lyle Ventures and Scottish Enterprise’s Scottish Venture Fund acquire BioFilm Limited
Tate & Lyle Ventures and Scottish Enterprise’s Scottish Venture Fund have acquired BioFilm Limited, a subsidiary of Devro plc and integrated manufacturer of dissolvable / edible films that carry active ingredients, designed for use in the nutraceutical and medical markets, through a newly formed company, BioFilm Holdings Limited.
- Avesthagen Launches MetaGrid(TM); Redefines Phyto-Fingerprinting
In an effort for industry to achieve absolute consistency in standardization of multi-constituent plant-based extracts, the research and development team of Avesthagen has unveiled its proprietary MetaGrid(TM) technology protocol.
- Avesthagen Launches MetaGrid(TM); Redefines Phyto-Fingerprinting
In an effort for industry to achieve absolute consistency in standardization of multi-constituent plant-based extracts, the research and development team of Avesthagen has unveiled its proprietary MetaGrid(TM) technology protocol.
- Avesthagen Launches MetaGrid(TM); Redefines Phyto-Fingerprinting
In an effort for industry to achieve absolute consistency in standardization of multi-constituent plant-based extracts, the research and development team of Avesthagen has unveiled its proprietary MetaGrid(TM) technology protocol.
- Avesthagen Launches MetaGrid(TM); Redefines Phyto-Fingerprinting
In an effort for industry to achieve absolute consistency in standardization of multi-constituent plant-based extracts, the research and development team of Avesthagen has unveiled its proprietary MetaGrid(TM) technology protocol.
- Avesthagen Launches MetaGrid(TM); Redefines Phyto-Fingerprinting
In an effort for industry to achieve absolute consistency in standardization of multi-constituent plant-based extracts, the research and development team of Avesthagen has unveiled its proprietary MetaGrid(TM) technology protocol.
- Avesthagen Launches MetaGrid(TM); Redefines Phyto-Fingerprinting
In an effort for industry to achieve absolute consistency in standardization of multi-constituent plant-based extracts, the research and development team of Avesthagen has unveiled its proprietary MetaGrid(TM) technology protocol.
- Avesthagen Launches MetaGrid(TM); Redefines Phyto-Fingerprinting
In an effort for industry to achieve absolute consistency in standardization of multi-constituent plant-based extracts, the research and development team of Avesthagen has unveiled its proprietary MetaGrid(TM) technology protocol.
- ChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit Compounds
ChromaDex Corp., (OTCBB: CDXC) has announced that its wholly owned subsidiary has entered into a world-wide license agreement with The Research Foundation of the State University of New York, on behalf of the University at Buffalo (SUNY Buffalo), to produce and market three classes of plant-based ingredients for nutraceutical, functional food, beverage, natural chemical, cosmetic and pharmaceutical industries.
- ChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit Compounds
ChromaDex Corp., (OTCBB: CDXC) has announced that its wholly owned subsidiary has entered into a world-wide license agreement with The Research Foundation of the State University of New York, on behalf of the University at Buffalo (SUNY Buffalo), to produce and market three classes of plant-based ingredients for nutraceutical, functional food, beverage, natural chemical, cosmetic and pharmaceutical industries.
- ChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit Compounds
ChromaDex Corp., (OTCBB: CDXC) has announced that its wholly owned subsidiary has entered into a world-wide license agreement with The Research Foundation of the State University of New York, on behalf of the University at Buffalo (SUNY Buffalo), to produce and market three classes of plant-based ingredients for nutraceutical, functional food, beverage, natural chemical, cosmetic and pharmaceutical industries.
- ChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit Compounds
ChromaDex Corp., (OTCBB: CDXC) has announced that its wholly owned subsidiary has entered into a world-wide license agreement with The Research Foundation of the State University of New York, on behalf of the University at Buffalo (SUNY Buffalo), to produce and market three classes of plant-based ingredients for nutraceutical, functional food, beverage, natural chemical, cosmetic and pharmaceutical industries.
- ChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit Compounds
ChromaDex Corp., (OTCBB: CDXC) has announced that its wholly owned subsidiary has entered into a world-wide license agreement with The Research Foundation of the State University of New York, on behalf of the University at Buffalo (SUNY Buffalo), to produce and market three classes of plant-based ingredients for nutraceutical, functional food, beverage, natural chemical, cosmetic and pharmaceutical industries.
- InterMed Discovery achieves Proof-of-Principle for IMD-026260
InterMed Discovery GmbH has announced that it has established proof-of-principle in a pre-clinical study for its optimized lead compound IMD-026260, an anti-cancer drug candidate.
- InterMed Discovery achieves Proof-of-Principle for IMD-026260
InterMed Discovery GmbH has announced that it has established proof-of-principle in a pre-clinical study for its optimized lead compound IMD-026260, an anti-cancer drug candidate.
- InterMed Discovery achieves Proof-of-Principle for IMD-026260
InterMed Discovery GmbH has announced that it has established proof-of-principle in a pre-clinical study for its optimized lead compound IMD-026260, an anti-cancer drug candidate.
- Hilton Will Discuss Market Impact of New Dosage and Delivery Systems With SupplySide West Suppliers and Manufacturers
Jeff Hilton, Integrated Marketing Group partner and co-founder, will discuss the impact of new delivery systems on the nutraceutical and functional food marketplace at the SupplySide West trade show and conference in Las Vegas later this month.
Hilton's education session, "New Dosage Forms Fuel Marketplace Opportunities," will be held on Friday, October 24 at 8 a.m. in Casanova room #601 in the Venetian and Sands Expo.
- Hilton Will Discuss Market Impact of New Dosage and Delivery Systems With SupplySide West Suppliers and Manufacturers
Jeff Hilton, Integrated Marketing Group partner and co-founder, will discuss the impact of new delivery systems on the nutraceutical and functional food marketplace at the SupplySide West trade show and conference in Las Vegas later this month.
Hilton's education session, "New Dosage Forms Fuel Marketplace Opportunities," will be held on Friday, October 24 at 8 a.m. in Casanova room #601 in the Venetian and Sands Expo.
- Hilton Will Discuss Market Impact of New Dosage and Delivery Systems With SupplySide West Suppliers and Manufacturers
Jeff Hilton, Integrated Marketing Group partner and co-founder, will discuss the impact of new delivery systems on the nutraceutical and functional food marketplace at the SupplySide West trade show and conference in Las Vegas later this month.
Hilton's education session, "New Dosage Forms Fuel Marketplace Opportunities," will be held on Friday, October 24 at 8 a.m. in Casanova room #601 in the Venetian and Sands Expo.
- Hilton Will Discuss Market Impact of New Dosage and Delivery Systems With SupplySide West Suppliers and Manufacturers
Jeff Hilton, Integrated Marketing Group partner and co-founder, will discuss the impact of new delivery systems on the nutraceutical and functional food marketplace at the SupplySide West trade show and conference in Las Vegas later this month.
Hilton's education session, "New Dosage Forms Fuel Marketplace Opportunities," will be held on Friday, October 24 at 8 a.m. in Casanova room #601 in the Venetian and Sands Expo.
- Hilton Will Discuss Market Impact of New Dosage and Delivery Systems With SupplySide West Suppliers and Manufacturers
Jeff Hilton, Integrated Marketing Group partner and co-founder, will discuss the impact of new delivery systems on the nutraceutical and functional food marketplace at the SupplySide West trade show and conference in Las Vegas later this month.
Hilton's education session, "New Dosage Forms Fuel Marketplace Opportunities," will be held on Friday, October 24 at 8 a.m. in Casanova room #601 in the Venetian and Sands Expo.
- Hilton Will Discuss Market Impact of New Dosage and Delivery Systems With SupplySide West Suppliers and Manufacturers
Jeff Hilton, Integrated Marketing Group partner and co-founder, will discuss the impact of new delivery systems on the nutraceutical and functional food marketplace at the SupplySide West trade show and conference in Las Vegas later this month.
Hilton's education session, "New Dosage Forms Fuel Marketplace Opportunities," will be held on Friday, October 24 at 8 a.m. in Casanova room #601 in the Venetian and Sands Expo.
- Hilton Will Discuss Market Impact of New Dosage and Delivery Systems With SupplySide West Suppliers and Manufacturers
Jeff Hilton, Integrated Marketing Group partner and co-founder, will discuss the impact of new delivery systems on the nutraceutical and functional food marketplace at the SupplySide West trade show and conference in Las Vegas later this month.
Hilton's education session, "New Dosage Forms Fuel Marketplace Opportunities," will be held on Friday, October 24 at 8 a.m. in Casanova room #601 in the Venetian and Sands Expo.
- Robinson Pharma Inc. Awarded cGMP Certification from Natural Products Association
Robinson Pharma Inc., (RPI) announced that it has been awarded cGMP Certification (#631-10-61753) by the Natural Products Association (NPA).
- Robinson Pharma Inc. Awarded cGMP Certification from Natural Products Association
Robinson Pharma Inc., (RPI) announced that it has been awarded cGMP Certification (#631-10-61753) by the Natural Products Association (NPA).
- Robinson Pharma Inc. Awarded cGMP Certification from Natural Products Association
Robinson Pharma Inc., (RPI) announced that it has been awarded cGMP Certification (#631-10-61753) by the Natural Products Association (NPA).
- Robinson Pharma Inc. Awarded cGMP Certification from Natural Products Association
Robinson Pharma Inc., (RPI) announced that it has been awarded cGMP Certification (#631-10-61753) by the Natural Products Association (NPA).
- Robinson Pharma Inc. Awarded cGMP Certification from Natural Products Association
Robinson Pharma Inc., (RPI) announced that it has been awarded cGMP Certification (#631-10-61753) by the Natural Products Association (NPA).
- World's Largest Natural and Organic Products Tradeshow Sets Record Attendance
Natural Products Expo West/SupplyExpo celebrated its 30th anniversary, March 11-14, 2010, at the Anaheim Convention Center in Calif. The event drew nearly 56,000 from across the industry, uniting entrepreneurs and established natural products alumni indicating a healthy market outlook for growth.
- World's Largest Natural and Organic Products Tradeshow Sets Record Attendance
Natural Products Expo West/SupplyExpo celebrated its 30th anniversary, March 11-14, 2010, at the Anaheim Convention Center in Calif. The event drew nearly 56,000 from across the industry, uniting entrepreneurs and established natural products alumni indicating a healthy market outlook for growth.
- World's Largest Natural and Organic Products Tradeshow Sets Record Attendance
Natural Products Expo West/SupplyExpo celebrated its 30th anniversary, March 11-14, 2010, at the Anaheim Convention Center in Calif. The event drew nearly 56,000 from across the industry, uniting entrepreneurs and established natural products alumni indicating a healthy market outlook for growth.
- World's Largest Natural and Organic Products Tradeshow Sets Record Attendance
Natural Products Expo West/SupplyExpo celebrated its 30th anniversary, March 11-14, 2010, at the Anaheim Convention Center in Calif. The event drew nearly 56,000 from across the industry, uniting entrepreneurs and established natural products alumni indicating a healthy market outlook for growth.
- World's Largest Natural and Organic Products Tradeshow Sets Record Attendance
Natural Products Expo West/SupplyExpo celebrated its 30th anniversary, March 11-14, 2010, at the Anaheim Convention Center in Calif. The event drew nearly 56,000 from across the industry, uniting entrepreneurs and established natural products alumni indicating a healthy market outlook for growth.
- World's Largest Natural and Organic Products Tradeshow Sets Record Attendance
Natural Products Expo West/SupplyExpo celebrated its 30th anniversary, March 11-14, 2010, at the Anaheim Convention Center in Calif. The event drew nearly 56,000 from across the industry, uniting entrepreneurs and established natural products alumni indicating a healthy market outlook for growth.
- Hongjiu Biotech Will Attend Asia Organic Expo 2010
Hongjiu Biotech Ginseng Health Food, which includes Instant Ginseng Food, Capsules and Ginseng Raw Material, has begun operations to develop global markets.
- Hongjiu Biotech Will Attend Asia Organic Expo 2010
Hongjiu Biotech Ginseng Health Food, which includes Instant Ginseng Food, Capsules and Ginseng Raw Material, has begun operations to develop global markets.
- Hongjiu Biotech Will Attend Asia Organic Expo 2010
Hongjiu Biotech Ginseng Health Food, which includes Instant Ginseng Food, Capsules and Ginseng Raw Material, has begun operations to develop global markets.
- Hongjiu Biotech Will Attend Asia Organic Expo 2010
Hongjiu Biotech Ginseng Health Food, which includes Instant Ginseng Food, Capsules and Ginseng Raw Material, has begun operations to develop global markets.
- Hongjiu Biotech Will Attend Asia Organic Expo 2010
Hongjiu Biotech Ginseng Health Food, which includes Instant Ginseng Food, Capsules and Ginseng Raw Material, has begun operations to develop global markets.
- Hongjiu Biotech Will Attend Asia Organic Expo 2010
Hongjiu Biotech Ginseng Health Food, which includes Instant Ginseng Food, Capsules and Ginseng Raw Material, has begun operations to develop global markets.
- Hongjiu Biotech Will Attend Asia Organic Expo 2010
Hongjiu Biotech Ginseng Health Food, which includes Instant Ginseng Food, Capsules and Ginseng Raw Material, has begun operations to develop global markets.
- Hongjiu Biotech Will Attend Asia Organic Expo 2010
Hongjiu Biotech Ginseng Health Food, which includes Instant Ginseng Food, Capsules and Ginseng Raw Material, has begun operations to develop global markets.
- Hongjiu Biotech Will Attend Asia Organic Expo 2010
Hongjiu Biotech Ginseng Health Food, which includes Instant Ginseng Food, Capsules and Ginseng Raw Material, has begun operations to develop global markets.
- Hongjiu Biotech Will Attend Asia Organic Expo 2010
Hongjiu Biotech Ginseng Health Food, which includes Instant Ginseng Food, Capsules and Ginseng Raw Material, has begun operations to develop global markets.
- Hongjiu Biotech Will Attend Asia Organic Expo 2010
Hongjiu Biotech Ginseng Health Food, which includes Instant Ginseng Food, Capsules and Ginseng Raw Material, has begun operations to develop global markets.
- Green Tea Extract May Delay or Prevent Alzheimer's
According to a new study sponsored by A. Holliday & Company and performed by Dr. Stephane Bastianetto at the Douglas Mental Health University Institute, McGill University in Montreal, a specific green tea extract may delay or prevent Alzheimer's disease and dementia.
- Green Tea Extract May Delay or Prevent Alzheimer's
According to a new study sponsored by A. Holliday & Company and performed by Dr. Stephane Bastianetto at the Douglas Mental Health University Institute, McGill University in Montreal, a specific green tea extract may delay or prevent Alzheimer's disease and dementia.
- Green Tea Extract May Delay or Prevent Alzheimer's
According to a new study sponsored by A. Holliday & Company and performed by Dr. Stephane Bastianetto at the Douglas Mental Health University Institute, McGill University in Montreal, a specific green tea extract may delay or prevent Alzheimer's disease and dementia.
- Green Tea Extract May Delay or Prevent Alzheimer's
According to a new study sponsored by A. Holliday & Company and performed by Dr. Stephane Bastianetto at the Douglas Mental Health University Institute, McGill University in Montreal, a specific green tea extract may delay or prevent Alzheimer's disease and dementia.
- Green Tea Extract May Delay or Prevent Alzheimer's
According to a new study sponsored by A. Holliday & Company and performed by Dr. Stephane Bastianetto at the Douglas Mental Health University Institute, McGill University in Montreal, a specific green tea extract may delay or prevent Alzheimer's disease and dementia.
- Green Tea Extract May Delay or Prevent Alzheimer's
According to a new study sponsored by A. Holliday & Company and performed by Dr. Stephane Bastianetto at the Douglas Mental Health University Institute, McGill University in Montreal, a specific green tea extract may delay or prevent Alzheimer's disease and dementia.
- Stay Tuned to What’s New in Canadian Regulatory Affairs with dicentra’s Free Webinar Series
- Stay Tuned to What’s New in Canadian Regulatory Affairs with dicentra’s Free Webinar Series
- Stay Tuned to What’s New in Canadian Regulatory Affairs with dicentra’s Free Webinar Series
- Stay Tuned to What’s New in Canadian Regulatory Affairs with dicentra’s Free Webinar Series
- Stay Tuned to What’s New in Canadian Regulatory Affairs with dicentra’s Free Webinar Series
- Vitamin E Capsules
- Sasso Energy Drink
|
MINNEAPOLIS – Cargill has received a patent for a breakthrough technology in taste tissue imaging and taste modification that is superior to the cell screening technology currently available in the flavor, food and beverage industries. The patented technology will allow Cargill to effectively discover taste modifiers – such as sweetness enhancers, bitterness blockers, savory enhancers and salt enhancers – and develop flavors that make food and beverage products taste better.
For example, Cargill’s technology can help identify natural molecules and flavor ingredients that can enhance the sweet taste of reduced-calorie foods and beverages or block bitter notes from others, such as processed foods. The system can provide an unparalleled depth of data for identifying potential taste enhancers, blockers and modifiers.
The new imaging technology allows Cargill scientists to actually see and measure the cellular response of taste cells to taste stimulants. This means they can simultaneously observe the cellular responses and interactions of all of the taste modalities – sweet, bitter, salty, sour and umami.
Cargill applies the new technology to customers mainly through its flavor systems business. “Cargill already had a wealth of knowledge and scientific resources in the flavor arena,” said Thomas Niederkorn, Americas beverage category director, Cargill Flavor Systems. “This new technology will allow us to expand our offerings into the ‘next generation’ of taste innovation.” According to Chris Mallett, Cargill corporate vice president of research and development, Cargill’s technology is revolutionary and differentiated in that it allows the company’s scientists to observe the interactions of all five taste modalities at the same time.
“As a result, this technology allows us to predict taste sensation and so help our customers deliver better-tasting consumer products to the marketplace,” said Mallett. Cargill developed the technology in partnership with the Monell Chemical Senses Center, a Philadelphia-based non-profit independent scientific institute dedicated to research on taste and smell.
The technology will be discussed at a session of the International Symposium on Olfaction and Taste on July 25 in San Francisco. ### Cargill is an international provider of food, agricultural and risk management products and services. With 158,000 employees in 66 countries, the company is committed to using its knowledge and experience to collaborate with customers to help them succeed. For more information, visit http://www.cargill.com. |